Axis IV psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity

American Journal on Addictions

Volumn 20, Issue 6, 2011, Pages 563-567

  Compton, Michael T ^a,e   Simmons, Chantelle M ^b   Weiss, Paul S ^c   West, Joyce C ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mid Atlantic Wellness Institute   (Bermuda)

^c EMORY UNIVERSITY   (United States)

^d AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PREVALENCE; PSYCHOSIS; PSYCHOSOCIAL DISORDER; SCREENING;

ADULT; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH SURVEYS; HUMANS; LIFE CHANGE EVENTS; MALE; MARIJUANA ABUSE; MOOD DISORDERS; PREVALENCE; PSYCHOTIC DISORDERS;

EID: 80054726043     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00184.x     Document Type: Article

References (21)

1. Compton WM, Grant BF, Colliver JD, et al,. Prevalence of marijuana use disorders in the United States-1991-1992 and 2001-2002. JAMA. 2004; 291: 2114-2121. (Pubitemid 38580155)
2. Regier DA, Farmer ME, Rae DS, et al,. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990; 264: 2511-2518.
3. Dixon L., Dual diagnosis of substance abuse in schizophrenia: Prevalence and impact on outcomes. Schizophr Res. 1999; 35 (Suppl): S93-S100. (Pubitemid 29133030)
4. Green AI, Salomon MS, Brenner MJ, et al,. Treatment of schizophrenia and comorbid substance use disorder. Curr Drug Targets: CNS Neurol Disord. 2002; 1: 129-139.
5. Green AI, Drake RE, Brunette MF, et al,. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry. 2007; 164: 402-408. (Pubitemid 46513152)
6. Grech A, Van Os, J, Jones PB, et al,. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry. 2005; 20: 349-353. (Pubitemid 40978562)
7. Raphael B, Wooding S, Stevens G, et al,. Comorbidity: Cannabis and complexity. J Psychiatr Pract. 2005; 11: 161-176. (Pubitemid 40756755)
8. Wilk J, West JC, Rae DS, et al,. Relationship of comorbid substance and alcohol use disorders to disability among patients in routine psychiatric practice. Am J Addict. 2006; 15: 180-185.
9. West JC, Herbeck DM, Bell CC, et al,. Race/ethnicity among psychiatric patients: Variations in diagnostic and clinical characteristics reported by practicing clinicians. Focus: J Lifelong Learning Psychiatr. 2006; 4: 48-56.
10. Pincus HA, Zarin DA, Tanielian TL, et al,. Psychiatric patients and treatments in 1997: Findings from the American Psychiatric Practice Research Network. Arch Gen Psychiatry. 1999; 56: 441-449. (Pubitemid 29215433)
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington, DC: American Psychiatric Association; 2000.
12. Compton MT, Weiss PS, West JC, et al,. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems. Social Psychiatr Psychiatric Epidemiol. 2005; 40: 939-946. (Pubitemid 43115894)
13. Shah BV, Barnwell BG, Bieler GS,. 2001 SUDAAN User's Manual, Release 8.0: Software for the Statistical Analysis of Correlated Data. Research Triangle Park: Research Triangle Institute, 2001.
14. Margolese HC, Malchy L, Negrete JC, et al,. Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences. Schizophr Res. 2004; 67: 157-166. (Pubitemid 38251445)
15. Di Forti M, Morrison PD, Butt A, et al,. Cannabis use and psychiatric and cognitive disorders: The chicken or the egg? Curr Opin Psychiatr. 2007; 20: 228-234. (Pubitemid 46588294)
16. Swartz MS, Wagner HR, Swanson JW, et al,. Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. Psychiatric Serv. 2006; 57: 1110-1116. (Pubitemid 44204903)
17. Heinrichs DW, Hanlon TE, Carpenter WT Jr,. The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984; 10: 388-398.
18. Greig RL, Baker A, Lewin TJ, et al,. Long-term follow-up of people with co-existing psychiatric and substance use disorders: Patterns of use and outcomes. Drug Alcohol Rev. 2006; 25: 249-258. (Pubitemid 43841694)
19. American Psychiatric Association. Practice guideline for the psychiatric evaluation of adults, second edition. Am J Psychiatr. 2006; 163 (Suppl): 1-36.
20. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders, second edition. Am J Psychiatr. 2007; 164 (Suppl): 1-124.
21. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatr. 2004; 161 (Suppl): 1-56.